ResMed Inc.

02/11/2026 | Press release | Distributed by Public on 02/11/2026 08:04

Resmed Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in the US

The new AirTouch™ F30i Comfort full face CPAP mask is designed to combine softness, breathability and a reliable seal for exceptional comfort

SAN DIEGO, FEBRUARY 11, 2026- Resmed (NYSE: RMD, ASX: RMD), the world's leading health technology company focused on sleep, breathing and care delivered in the home, today announced the launch of the AirTouch™ F30i Comfort mask in the United States, a new CPAP (continuous positive airway pressure) full face mask. With a soft, breathable1 fabric, the AirTouch F30i Comfort is designed to help more people start and stay on CPAP therapy.

The AirTouch F30i Comfort reflects Resmed's dedication to its 2030 goal of empowering 500 million people to achieve their full health potential. Following the mask's introduction in Australia and Canada, the U.S. launch reinforces Resmed's focus on advancing comfort-led CPAP innovation for patients worldwide. Building on the AirTouch F30i Clear, the AirTouch F30i Comfort features an ultra compact design, fabric cushion and fully fabric-wrapped frame designed to deliver an elevated comfort experience. The AirTouch F30i Comfort also complements the successful track record of the AirTouch N30i, a fabric wrapped nasal cushion mask that also features a fabric-wrapped frame.

"At Resmed, we're focused on designing health technologies that people want to use night after night," said Justin Leong, chief product officer at Resmed. "That means designing masks that help make it easier for people to start and stay on CPAP therapy. With the AirTouch F30i Comfort, we're extending our fabric-mask innovation to more patients, combining softness, breathability and performance to help people sleep better, breathe better and live healthier lives."

Obstructive sleep apnea (OSA) is a common but serious condition that causes breathing to stop or slow during sleep due to partial or total collapse of the airway.2 In the U.S., OSA affects an estimated 61 million adults today, a number projected to reach nearly 77 million by 2050.3 Yet more than 80% of cases go undiagnosed and untreated4, raising the risk for serious health conditions, such as high blood pressure, heart disease, type 2 diabetes and stroke.5 

Key Features of the AirTouch F30i Comfort

  • Designed for comfort: Featuring Resmed's patented ComfiSoft™ cushion and frame with breathable and moisture-wicking fabric1, the mask is designed to deliver maximum comfort without compromising on seal.
  • Breakthrough innovation: Pushing the boundaries of textile and manufacturing innovation, the AirTouch F30i Comfort combines durability, softness and flexibility designed to gently contour to the face.
  • Customised Fit: The AirTouch F30i Comfort is developed using thousands of digital biomarkers to help provide a tailored fit. The ComfiSoft fabric cushion with AdaptiSeal™ technology combines fabric and silicone and is designed to gently adapt to the face, creating a secure seal that moves with you as you sleep. Available in three cushion sizes - Small-Wide, Medium and Large -and three frame sizes - Small, Standard and Large - the AirTouch F30i Comfort is designed to deliver greater personalization than ever.

The AirTouch F30i Comfort will be available across the U.S beginning February 11, 2026. The mask is also available in Australia, New Zealand and Canada. The mask is compatible with Resmed's AirCurve™ 11, AirSense™ 11, AirCurve 10, AirSense 10, S9 Autoset and select VPAP devices. For more information and a full list of compatible devices, visit https://www.resmed.com/en-us/health-professionals/campaigns/airtouch-f30i-comfort/.

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we're redefining sleep health at  Resmed.com and follow @Resmed.

For Media:
Caela Shay
[email protected]
[email protected]

For Investors:
Salli Schwartz
[email protected]
[email protected]

1 Resmed internal testing for the moisture-wicking properties of fabric, ID: A5498268

2 Cumpston & Chen. Sleep apnea syndrome. StatPearls Publishing. 2023.

3 Boers E, Malhotra A, et al. Projecting the 30-year burden of obstructive sleep apnea in the USA: an open-cohort modelling study. Lancet Regional Health - Americas. 2025; PIIS2213-2600(25)00243-7. doi:10.1016/S2213-2600(25)00243-7.

4 Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(3):479-504.

5 Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2021; 144(3): e56-e67.

ResMed Inc. published this content on February 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 11, 2026 at 14:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]